rs372408513
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001384474.1(LOXHD1):c.683C>T(p.Pro228Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000864 in 1,551,706 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001384474.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LOXHD1 | ENST00000642948.1 | c.683C>T | p.Pro228Leu | missense_variant | Exon 6 of 41 | NM_001384474.1 | ENSP00000496347.1 | |||
LOXHD1 | ENST00000536736.5 | c.683C>T | p.Pro228Leu | missense_variant | Exon 6 of 40 | 5 | ENSP00000444586.1 | |||
LOXHD1 | ENST00000441551.6 | c.683C>T | p.Pro228Leu | missense_variant | Exon 6 of 39 | 5 | ENSP00000387621.2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000121 AC: 19AN: 156942Hom.: 1 AF XY: 0.000169 AC XY: 14AN XY: 83072
GnomAD4 exome AF: 0.0000765 AC: 107AN: 1399432Hom.: 1 Cov.: 30 AF XY: 0.0000840 AC XY: 58AN XY: 690208
GnomAD4 genome AF: 0.000177 AC: 27AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74454
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 77 Uncertain:2
- -
- -
not specified Uncertain:1
The p.Pro228Leu variant in LOXHD1 has been previously identified by our laborato ry in an individual with hearing loss that can be explained by pathogenic varian ts in another gene. It has been identified in 3/7912 South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs 372408513). Although this variant has been seen in the general population, its f requency is not high enough to rule out a pathogenic role. Computational predict ion tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Pro228 Leu variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.683C>T (p.P228L) alteration is located in exon 6 (coding exon 6) of the LOXHD1 gene. This alteration results from a C to T substitution at nucleotide position 683, causing the proline (P) at amino acid position 228 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at